Vascular Senescence as an Adaptive Signal for Intergenerational Resource Allocation

Background

The disposable soma and antagonistic pleiotropy frameworks explain age‑related vascular decline as a byproduct of selection waning after reproduction[1]2]3]. Yet the conservation of pathways such as mTOR, sirtuins and autophagy across taxa suggests they may be co‑opted for functions beyond simple damage accumulation[4]]5]. Recent work shows that senescent endothelial cells secrete a distinct SASP enriched in microRNA‑laden extracellular vesicles that can travel via the bloodstream to reproductive tissues[6].

Hypothesis

We propose that late‑life vascular senescence is not merely a neglected side effect but an evolved signaling mechanism that modulates offspring fitness by adjusting maternal resource allocation. Specifically, endothelial‑derived SASP factors act as circulating cues that reduce maternal investment in current reproduction, thereby favoring survival and investment in existing or future kin. This creates a feedback loop where vascular aging directly influences intergenerational trade‑offs, making it a selectable trait rather than a passive byproduct.

Mechanistic Reasoning

1. SASP Composition – Endothelial senescence upregulates VCAM‑1, IL‑6 and specific miRNAs (e.g., miR‑34a, miR‑146a) that are packaged into exosomes and circulate to the placenta, uterus or mammary gland[6].
2. Signal Reception – These molecules bind receptors on trophocytes or mammary epithelium, activating pathways (e.g., p53‑dependent apoptosis, mTORC1 suppression) that diminish nutrient transport or milk synthesis[5]).
3. Fitness Outcome – Reduced maternal investment lowers the metabolic load on the mother, extending her post‑reproductive lifespan and increasing the probability of grand‑maternal care, which enhances offspring survival in kin‑structured populations[1]2].
4. Evolutionary Stability – Because the signal is tied to vascular health—a trait already under early‑life selection for blood pressure regulation—mutations that strengthen the SASP‑mediated trade‑off can be favored without compromising early fecundity.

Testable Predictions

• Prediction 1: Pharmacological inhibition of endothelial exosome release (e.g., GW4869) in middle‑aged mammals will increase maternal nutrient transfer to pups and decrease markers of vascular senescence without affecting early‑life fertility.
• Prediction 2: Maternal mice overexpressing endothelial VCAM‑1 will exhibit reduced litter growth rates but extended post‑reproductive survival compared with controls.
• Prediction 3: Populations with historically high kin‑structured social systems (e.g., eusocial insects, cooperative breeders) will show endothelial SASP profiles predictive of greater alloparental investment.

Experimental Approach

1. Model: Use inducible, endothelial‑specific Cre lines to delete Rab27a (exosome release) or overexpress VCAM-1 in mice.
2. Readouts: Measure plasma exosome miRNA content, uterine/placental nutrient transporter expression (GLUT1, FATP4), litter weight gain, maternal aortic PWV, and survival post‑weaning.
3. Controls: Littermate wild‑type, vehicle‑treated, and rapamycin‑treated groups to separate mTOR effects from exosome signaling.
4. Comparative: Endothelial SASP profiling in species with varying degrees of cooperative breeding (e.g., meerkats vs. solitary rodents) using mass spectrometry and small‑RNA sequencing.

Implications

If validated, this hypothesis reframes vascular aging as a communicative interface between somatic state and kin fitness, suggesting that longevity interventions should consider not only cellular damage but also the signaling consequences of senescence. Therapies that blunt detrimental SASP components while preserving beneficial intergenerational cues could extend healthspan without undermining evolved adaptive mechanisms.